Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD
Maddalena Noviello, Francesco Saverio Tedesco, Attilio Bondanza, et al.
Molecular Therapy (2014) Vol. 22, Iss. 7, pp. 1342-1352
Open Access | Times Cited: 20

Showing 20 citing articles:

Duchenne Muscular Dystrophy: From Diagnosis to Therapy
Maria Falzarano, C. Scotton, Chiara Passarelli, et al.
Molecules (2015) Vol. 20, Iss. 10, pp. 18168-18184
Open Access | Times Cited: 265
Intra‐arterial transplantation of HLA ‐matched donor mesoangioblasts in Duchenne muscular dystrophy
Giulio Cossu, Stefano C. Previtali, Sara Napolitano, et al.
EMBO Molecular Medicine (2015) Vol. 7, Iss. 12, pp. 1513-1528
Open Access | Times Cited: 157
Cardiovascular Disease in Duchenne Muscular Dystrophy
Taylor Schultz, F Raucci, Fadi N. Salloum
JACC Basic to Translational Science (2022) Vol. 7, Iss. 6, pp. 608-625
Open Access | Times Cited: 33
Stem cell therapy for muscular dystrophies
Stefano Biressi, Antonio Filareto, Thomas A. Rando
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 5652-5664
Open Access | Times Cited: 48
Muscle Interstitial Cells: A Brief Field Guide to Non-satellite Cell Populations in Skeletal Muscle
Francesco Saverio Tedesco, Louise A. Moyle, Eusebio Perdiguero
Methods in molecular biology (2017), pp. 129-147
Open Access | Times Cited: 46
Stem Cell Transplantation for Muscular Dystrophy: The Challenge of Immune Response
Sara M. Maffioletti, Maddalena Noviello, Karen English, et al.
BioMed Research International (2014) Vol. 2014, pp. 1-12
Open Access | Times Cited: 43
Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy
Maria Siemionow, Joanna Cwykiel, Ahlke Heydemann, et al.
Stem Cell Reviews and Reports (2018) Vol. 14, Iss. 2, pp. 189-199
Open Access | Times Cited: 39
Invited review: Stem cells and muscle diseases: advances in cell therapy strategies
Elisa Négroni, Teresa Gidaro, Anne Bigot, et al.
Neuropathology and Applied Neurobiology (2014) Vol. 41, Iss. 3, pp. 270-287
Closed Access | Times Cited: 41
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy
Maria Siemionow, Paulina Langa, Sonia Brodowska, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 8, pp. 2872-2892
Open Access | Times Cited: 17
Circulating Biomarkers for Duchenne Muscular Dystrophy
Annemieke Aartsma‐Rus, Pietro Spitali
Journal of Neuromuscular Diseases (2015) Vol. 2, Iss. s2, pp. S49-S58
Open Access | Times Cited: 30
Human Dystrophin Expressing Chimeric (DEC) Cell Therapy Ameliorates Cardiac, Respiratory, and Skeletal Muscle's Function in Duchenne Muscular Dystrophy
Maria Siemionow, Paulina Langa, Michał Harasymczuk, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 10, pp. 1406-1418
Open Access | Times Cited: 22
Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy
Maria Siemionow, Joanna Cwykiel, Ahlke Heydemann, et al.
Stem Cell Reviews and Reports (2018) Vol. 14, Iss. 3, pp. 370-384
Open Access | Times Cited: 27
Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy
Maria Siemionow, Mohammad S. Malik, Paulina Langa, et al.
Stem Cell Reviews and Reports (2019) Vol. 15, Iss. 6, pp. 827-841
Open Access | Times Cited: 22
Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic Mice
Bryan Holvoet, Mattia Quattrocelli, Sarah Belderbos, et al.
Stem Cell Reports (2015) Vol. 5, Iss. 6, pp. 1183-1195
Open Access | Times Cited: 18
Cell Therapy Strategies on Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications
Ayberk Akat, Erdal Karaöz
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 138-158
Closed Access | Times Cited: 5
Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model
Maria Siemionow, Erzsebet Szilagyi, Joanna Cwykiel, et al.
Stem Cells and Development (2020) Vol. 30, Iss. 4, pp. 190-202
Closed Access | Times Cited: 14
Pericytes in Muscular Dystrophies
Louise A. Moyle, Francesco Saverio Tedesco, Sara Benedetti
Advances in experimental medicine and biology (2019), pp. 319-344
Open Access | Times Cited: 11
Fate of mesoangioblasts in a vaginal birth injury model: influence of the route of administration
Marina Gabriela Monteiro Carvalho Mori da Cunha, Giorgia Giacomazzi, Geertje Callewaert, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Aquapuncture Using Stem Cell Therapy to Treat Mdx Mice
Greyson Vitor Zanatta Esper, Graciela Conceição Pignatari, Márcio Nogueira Rodrigues, et al.
Evidence-based Complementary and Alternative Medicine (2015) Vol. 2015, pp. 1-7
Open Access | Times Cited: 5
Delayed onset of Duchenne muscular dystrophy in a case of 22-year male with normal developmental milestone
Sameer Dhabalia, Shivani Malpani, Sandeep Shrivastav
Medical Science (2023) Vol. 27, Iss. 132, pp. 1-9
Open Access
Page 1

Scroll to top